Showing results (261-270 of 14,152) with videos related to

Sort By:
Pageof 1,416
BMC Neuroscience|April 22, 2015
Expression and cellular localization of hepcidin mRNA and protein in normal rat brainRuma Raha-Chowdhury, Animesh Alexander Raha, Serhiy Forostyak, et al.
Pain Medicine (Malden, Mass.)|June 23, 2011
Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?Reiner Benecke, Axel Heinze, Gerhard Reichel, et al.
Journal of Computer Assisted Tomography|July 1, 1995
MRI of the brain in Wilson disease: T2 signal loss under therapyV Engelbrecht, G Schlaug, H Hefter, et al.
Toxins|August 6, 2021
Continuous Increase of Efficacy under Repetitive Injections of Botulinum Toxin Type/A beyond the First Treatment for Adult Spastic Foot DropHarald Hefter, Werner Nickels, Dietmar Rosenthal, et al.
Brain and Language|October 1, 1992
Impairment of temporal organization of speech in basal ganglia diseasesJ Volkmann, H Hefter, H W Lange, et al.
Cancer Research|January 1, 1978
Impairment of Na+-dependent amino acid transport in a cultured human T-cell line by hyperthermia and irradiationL Kwock, P S Lin, K Hefter, et al.
Medicina (Kaunas, Lithuania)|January 21, 2022
The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation-A Monocentric Cross-Sectional Pilot StudyHarald Hefter, Isabelle Schomaecker, Max Schomaecker, et al.
Wiener Klinische Wochenschrift|October 28, 2004
[Treatment of the spastic drop foot with botulinum toxin type A in adult patients]B Voller, D Földy, H Hefter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1990
Disturbances in human arm movement trajectory due to mild cerebellar dysfunctionS H Brown, H Hefter, M Mertens, et al.
Pain|June 6, 2006
Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre studyHartmut Göbel, Axel Heinze, Gerhard Reichel, et al.
Pageof 1,416